Equity Analysis

MF Holdings
    Glaxosmithkline Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Multinational
    BSE Code
    ISIN Demat
    Book Value()
    500660
    INE159A01016
    98.8545682
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    GLAXO
    50.19
    42500.59
    EPS(TTM)
    Face Value()
    Div & Yield %:
    49.99
    10
    1.28
     
As on: Feb 24, 2025 01:55 AM
Scheme Name Inv Date Amount Invested ( in Cr) Net Assets(%) Total NAV ( in Cr)
SBI Magnum Midcap Fund 31-Jan-25 257.03 1.21 21177.20
Kotak Equity Opportunities Fund 31-Jan-25 217.49 0.89 24533.81
Aditya Birla SL ELSS Tax Saver Fund 31-Jan-25 183.54 1.25 14626.04
Nippon India Pharma Fund 31-Jan-25 164.65 2.02 8160.74
Nippon India Growth Fund 31-Jan-25 110.52 0.33 33033.09
SBI Dividend Yield Fund 31-Jan-25 88.97 0.97 9205.99
Aditya Birla SL MNC Fund 31-Jan-25 87.72 2.48 3530.52
Quant Mid Cap Fund 31-Jan-25 81.75 0.95 8608.01
Kotak Flexi Cap Fund 31-Jan-25 78.95 0.16 49112.04
Bandhan ELSS Tax Saver Fund 31-Jan-25 65.25 0.99 6620.13
1 2 3 4